Disc Medicine Inc reports results for the quarter ended in March - Earnings Summary

Disc Medicine

13/05/2024 14:31

* Disc Medicine Inc  IRON.OQ  reported a quarterly adjusted
loss
of $1.09​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-1.20.  The mean expectation of seven analysts for the quarter
was for a loss of 100 cents per share. Wall Street expected
results to range from $-1.22 to -76 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Disc Medicine Inc's reported EPS for the quarter was a
loss of
$1.09​.
    * The company reported a quarterly loss of $26.95 million.
    * Disc Medicine Inc shares had fallen by 51.2% this
quarter and
lost 47.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 19.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Disc Medicine Inc
is $50.00 
This summary was machine generated from LSEG data May 13 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.00          -1.09          Missed
 Dec. 31 2023      -0.78          -0.90          Missed
 Sep. 30 2023      -0.80          -0.58          Beat
 Jun. 30 2023      -0.86          -0.74          Beat